Apnimed, Inc. (APMD) stock
APMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026
$17.80+1.52 (+9.34%)
Close on Nov 17, 2026Market cap $85.47MP/E –Yield –
Apnimed EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Apnimed
Apnimed has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?